Efficacy of AesyBite Active in Reducing Sleep Bruxism Activity

NCT ID: NCT06153810

Last Updated: 2025-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-17

Study Completion Date

2025-11-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall objective of the clinical investigation is to evaluate whether the use of the AesyBite Active reduces the bruxism activity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Bruxism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Delayed stimulation

Biofeedback treatment is started after three weeks of observation

Group Type EXPERIMENTAL

Biofeedback stimulation

Intervention Type DEVICE

Delivery of the vibratory biofeedback stimulus

Early stimulation

Biofeedback treatment is started after two weeks of observation

Group Type EXPERIMENTAL

Biofeedback stimulation

Intervention Type DEVICE

Delivery of the vibratory biofeedback stimulus

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biofeedback stimulation

Delivery of the vibratory biofeedback stimulus

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 to 70 years, in good general health.
* Presence of at least one of the following:

* sleeping partner's report of tooth grinding sounds during sleep for at least three nights per week within the last 6 months,
* hypertrophy of the masseter muscle upon digital palpation.
* Presence of at least one of the following:

* signs of tooth attrition or shiny spots on dental restorations,
* self-report of masticatory muscle fatigue or pain at awakening.
* Previous prescription of a night splint for bruxism.
* Able to understand and follow the protocol and complete the self-administered paper questionnaires.
* Able to provide written informed consent to study participation and storage and processing of study data

Exclusion Criteria

* Allergic to Ethylene-Vinyl Acetate (EVA) copolymer.
* With more than two missing molars (excluding third molars).
* Ongoing orthodontic treatment (e.g. teeth alignment).
* With major neurological or psychiatric disorders including substance dependence.
* Using a removable dental prosthesis.
* Using a medication with known effects on sleep or motor behavior.
* Suffering from periodontal disease.
* With occlusal or jaw abnormalities that prevent the wearing of a normal dental splint.
* Participants with pacemakers.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aesyra SA

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marcello Maddalone

Role: PRINCIPAL_INVESTIGATOR

Fondazione IRCCS San Gerardo dei Tintori

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fondazione Irccs San Gerardo Dei Tintori

Monza, Monza E Brianza, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ABA020-CIP-001

Identifier Type: -

Identifier Source: org_study_id